(888) 31-NDASA info@NDASA.com
  • Facebook
  • Twitter
  • Instagram
  • RSS
  • Facebook
  • Twitter
  • Instagram
  • RSS
  • NDASA
  • NDASA University
  • Member Login
0 Items
NDASA
  • About
    • Welcome DATIA Members
    • Leadership
  • Training
    • NDASA University
      • My Courses
    • NDASA University Partner Program
    • Webinars
      • Webinar Library
    • Accreditation
    • Mentorship
  • Get involved
    • Committees
    • International Partnership
    • Become a Trainer
    • State Affiliate Caucus
    • Our Federal PAC
    • Board of Directors
  • Join us
    • Member Benefits
    • Sponsorships & Advertising
    • Accreditation
    • Preferred Provider
  • News
    • Resources
  • Events
    • 2023 Conference & Trade Show
    • 2023 Conference Highlights
  • Shop
  • Support
    • Sponsorships & Advertising
  • Help
Select Page
Study Finds that Marijuana and Hallucinogen Use Reach Historic Highs Among U.S. Adults

Study Finds that Marijuana and Hallucinogen Use Reach Historic Highs Among U.S. Adults

by NDASA | Aug 28, 2023 | Drug & Alcohol Testing, Feature, Substance Use, Workplace Safety

Use of marijuana and hallucinogens among adults 19 to 50 reached an all-time high in 2022, according to the Monitoring the Future Panel Study, which is sponsored annually by the National Institutes of Health. Furthermore, the study found that alcohol use among adults...

Search this site

Stay in touch

  • Follow
  • Follow
  • Follow
  • Follow

Give to NDASA

Invest in safe and drug-free communities and workplaces and support NDASA.
Give now

Latest News & Updates

  • Sep 19, 2023DOT Q & A – 9/20
  • Sep 14, 2023From the Executive Director’s Desk
  • Sep 12, 2023The Critical Importance of Regularly Changing Online Passwords in the Drug Testing Industry
  • Sep 11, 2023What happens when a DOT employee has a testing violation recorded in the FMCSA Clearinghouse and then changes modes?
  • Sep 11, 2023State Law Update 2023: Employer Limitations in Workplace Drug & Alcohol Testing

Topics We Track

  • Advocacy (3)
  • Business Development (3)
  • Committee Reports (1)
  • DOT (10)
  • Drug & Alcohol Testing (33)
  • Drug Legislation (9)
  • Feature (73)
  • FMCSA (5)
  • For Drug Testing Industry Professionals (14)
  • For Employers and Workplace Safety & Wellness Professionals (12)
  • Industry News (24)
  • Marijuana & CBD (15)
  • Member Benefits (3)
  • Membership (6)
  • NDASA Conference (12)
  • NDASA Guidance (4)
  • Newsletter Only (5)
  • Opioids (2)
  • Resources (21)
  • Substance Use (2)
  • Substance Use/Addiction (6)
  • Training (2)
  • Uncategorized (10)
  • Workplace Safety (10)

  • DOT Q & A – 9/20
  • From the Executive Director’s Desk
  • The Critical Importance of Regularly Changing Online Passwords in the Drug Testing Industry
  • What happens when a DOT employee has a testing violation recorded in the FMCSA Clearinghouse and then changes modes?
  • State Law Update 2023: Employer Limitations in Workplace Drug & Alcohol Testing

Legal Documents

  • Articles of Incorporation
  • Exemption Letter
  • IRS Designation Letter

NDASA Bylaws

  • Bylaws

Careers

Visit our job board

NDASA Policies

  • Privacy Policy
  • Security Policy
  • Refund Policy
  • Shipping Policy

U.S. Chamber of Commerce logo

© 2023 National Drug and Alcohol Screening Association • All Rights Reserved • Web Powered by Media Salad